Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | January 31, 2023 01:30pm

Gainers

  • Hillstream BioPharma (NASDAQ:HILS) stock rose 95.2% to $1.31 during Tuesday's regular session. As of 12:30 EST, Hillstream BioPharma's stock is trading at a volume of 61.7 million, which is 19995.1% of its average full-day volume over the last 100 days. The company's market cap stands at $15.1 million.
  • Hyperfine (NASDAQ:HYPR) shares increased by 32.65% to $1.15. As of 12:30 EST, Hyperfine's stock is trading at a volume of 19.1 million, which is 6640.9% of its average full-day volume over the last 100 days. The company's market cap stands at $81.5 million.
  • Erytech Pharma (NASDAQ:ERYP) shares rose 26.38% to $0.91. The current volume of 297.8K shares is 760.1% of Erytech Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $28.2 million.
  • Palisade Bio (NASDAQ:PALI) shares rose 24.55% to $2.79. As of 12:30 EST, this security is trading at a volume of 2.7 million shares, making up 82.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.6 million.
  • MyMD Pharmaceuticals (NASDAQ:MYMD) shares increased by 22.56% to $2.67. As of 12:30 EST, this security is trading at a volume of 1.3 million shares, making up 746.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $105.4 million.
  • Sientra (NASDAQ:SIEN) stock moved upwards by 22.31% to $2.17. The current volume of 632.9K shares is 327.6% of Sientra's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $21.8 million.

Losers

  • NewAmsterdam Pharma (NASDAQ:NAMS) stock declined by 23.2% to $13.6 during Tuesday's regular session. Trading volume for NewAmsterdam Pharma's stock is 299.8K as of 12:30 EST. This is 615.9% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion.
  • Evoke Pharma (NASDAQ:EVOK) stock decreased by 18.01% to $4.71. The current volume of 101.1K shares is 293.7% of Evoke Pharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $15.7 million.
  • Heart Test Laboratories (NASDAQ:HSCS) shares fell 13.38% to $2.04. As of 12:30 EST, Heart Test Laboratories's stock is trading at a volume of 2.2 million, which is 180.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.9 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares decreased by 12.09% to $0.8. As of 12:30 EST, this security is trading at a volume of 520.0K shares, making up 18.0% of its average full-day volume over the last 100 days. The company's market cap stands at $10.3 million.
  • G Medical Innovations (NASDAQ:GMVD) shares fell 11.83% to $4.77. As of 12:30 EST, this security is trading at a volume of 860.8K shares, making up 110.1% of its average full-day volume over the last 100 days. The company's market cap stands at $6.7 million.
  • Scilex Holding (NASDAQ:SCLX) stock declined by 10.7% to $7.76. Scilex Holding's stock is trading at a volume of 157.6K shares as of 12:30 EST. This is 68.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ERYP EVOK GMVD HILS HSCS HYPR MYMD NAMS PALI RNAZ SCLX SIEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist